181 related articles for article (PubMed ID: 33491123)
21. Motor unit number index correlates with disability in Charcot-Marie-Tooth disease.
Bas J; Delmont E; Fatehi F; Salort-Campana E; Verschueren A; Pouget J; Lefebvre MN; Grapperon AM; Attarian S
Clin Neurophysiol; 2018 Jul; 129(7):1390-1396. PubMed ID: 29729594
[TBL] [Abstract][Full Text] [Related]
22. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
23. Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A.
Eichinger K; Sowden JE; Burns J; McDermott MP; Krischer J; Thornton J; Pareyson D; Scherer SS; Shy ME; Reilly MM; Herrmann DN
Front Neurol; 2022; 13():930435. PubMed ID: 35832173
[TBL] [Abstract][Full Text] [Related]
24. Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study.
Chao HC; Chou CT; Lee YC; Lin KP
J Neurol Sci; 2015 Nov; 358(1-2):213-20. PubMed ID: 26349404
[TBL] [Abstract][Full Text] [Related]
25. Nerve ultrasound depicts peripheral nerve enlargement in patients with genetically distinct Charcot-Marie-Tooth disease.
Noto Y; Shiga K; Tsuji Y; Mizuta I; Higuchi Y; Hashiguchi A; Takashima H; Nakagawa M; Mizuno T
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):378-84. PubMed ID: 25091364
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
[TBL] [Abstract][Full Text] [Related]
27. In vivo confocal microscopy of Meissner corpuscles as a novel sensory measure in CMT1A.
Almodovar JL; Ferguson M; McDermott MP; Lewis RA; Shy ME; Herrmann DN
J Peripher Nerv Syst; 2011 Sep; 16(3):169-74. PubMed ID: 22003930
[TBL] [Abstract][Full Text] [Related]
28. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
Attarian S; Vallat JM; Magy L; Funalot B; Gonnaud PM; Lacour A; Péréon Y; Dubourg O; Pouget J; Micallef J; Franques J; Lefebvre MN; Ghorab K; Al-Moussawi M; Tiffreau V; Preudhomme M; Magot A; Leclair-Visonneau L; Stojkovic T; Bossi L; Lehert P; Gilbert W; Bertrand V; Mandel J; Milet A; Hajj R; Boudiaf L; Scart-Grès C; Nabirotchkin S; Guedj M; Chumakov I; Cohen D
Orphanet J Rare Dis; 2014 Dec; 9():199. PubMed ID: 25519680
[TBL] [Abstract][Full Text] [Related]
29. A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot-Marie-Tooth neuropathy 1A.
Xu IRL; Danzi MC; Ruiz A; Raposo J; De Jesus YA; Reilly MM; Cortese A; Shy ME; Scherer SS; Herrmann DN; Fridman V; Baets J; Saporta M; Seyedsadjadi R; Stojkovic T; Claeys KG; Patel P; Feely S; Rebelo AP; ; Dohrn MF; Züchner S
J Peripher Nerv Syst; 2024 Jun; 29(2):202-212. PubMed ID: 38581130
[TBL] [Abstract][Full Text] [Related]
30. NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.
Jennings MJ; Kagiava A; Vendredy L; Spaulding EL; Stavrou M; Hathazi D; Grüneboom A; De Winter V; Gess B; Schara U; Pogoryelova O; Lochmüller H; Borchers CH; Roos A; Burgess RW; Timmerman V; Kleopa KA; Horvath R
Brain; 2022 Nov; 145(11):3999-4015. PubMed ID: 35148379
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of functional surgery associated with early intensive rehabilitation therapy in Charcot-Marie-Tooth Type 1A disease.
Ferraro F; Dusina B; Carantini I; Strambi R; Galante E; Gaiani L
Eur J Phys Rehabil Med; 2017 Oct; 53(5):788-793. PubMed ID: 28264542
[TBL] [Abstract][Full Text] [Related]
32. Quantitative assessment of muscle echogenicity in Charcot-Marie-Tooth disease type 1A by automatic thresholding methods.
Kitaoji T; Noto YI; Kojima Y; Tsuji Y; Mizuno T; Nakagawa M
Clin Neurophysiol; 2021 Oct; 132(10):2693-2701. PubMed ID: 34294566
[TBL] [Abstract][Full Text] [Related]
33. Nerve conduction velocity in CMT1A: what else can we tell?
Manganelli F; Pisciotta C; Reilly MM; Tozza S; Schenone A; Fabrizi GM; Cavallaro T; Vita G; Padua L; Gemignani F; Laurà M; Hughes RA; Solari A; Pareyson D; Santoro L;
Eur J Neurol; 2016 Oct; 23(10):1566-71. PubMed ID: 27412484
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography.
Fortanier E; Ogier AC; Delmont E; Lefebvre MN; Viout P; Guye M; Bendahan D; Attarian S
Eur J Neurol; 2020 Aug; 27(8):1382-1389. PubMed ID: 32391944
[TBL] [Abstract][Full Text] [Related]
35. Pain assessment in Charcot-Marie-Tooth (CMT) disease.
Ribiere C; Bernardin M; Sacconi S; Delmont E; Fournier-Mehouas M; Rauscent H; Benchortane M; Staccini P; Lantéri-Minet M; Desnuelle C
Ann Phys Rehabil Med; 2012 Apr; 55(3):160-73. PubMed ID: 22475878
[TBL] [Abstract][Full Text] [Related]
36. Outcome measures in the clinical evaluation of ambulatory Charcot-Marie-Tooth 1A subjects.
Mori L; Prada V; Signori A; Pareyson D; Piscosquito G; Padua L; Pazzaglia C; Fabrizi GM; Smania N; Picelli A; Schenone A;
Eur J Phys Rehabil Med; 2019 Feb; 55(1):47-55. PubMed ID: 29898585
[TBL] [Abstract][Full Text] [Related]
37. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.
Murphy SM; Herrmann DN; McDermott MP; Scherer SS; Shy ME; Reilly MM; Pareyson D
J Peripher Nerv Syst; 2011 Sep; 16(3):191-8. PubMed ID: 22003934
[TBL] [Abstract][Full Text] [Related]
38. High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.
Lewis RA; McDermott MP; Herrmann DN; Hoke A; Clawson LL; Siskind C; Feely SM; Miller LJ; Barohn RJ; Smith P; Luebbe E; Wu X; Shy ME;
JAMA Neurol; 2013 Aug; 70(8):981-7. PubMed ID: 23797954
[TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.
Sheth S; Francies K; Siskind CE; Feely SM; Lewis RA; Shy ME
J Peripher Nerv Syst; 2008 Dec; 13(4):299-304. PubMed ID: 19192070
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A.
Fledrich R; Mannil M; Leha A; Ehbrecht C; Solari A; Pelayo-Negro AL; Berciano J; Schlotter-Weigel B; Schnizer TJ; Prukop T; Garcia-Angarita N; Czesnik D; Haberlová J; Mazanec R; Paulus W; Beissbarth T; Walter MC; Triaal C; Hogrel JY; Dubourg O; Schenone A; Baets J; De Jonghe P; Shy ME; Horvath R; Pareyson D; Seeman P; Young P; Sereda MW
J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):941-952. PubMed ID: 28860329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
